G Riemekasten
Overview
Explore the profile of G Riemekasten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matrisch L, Grasshoff H, Muller A, Schinke S, Riemekasten G
Scand J Rheumatol
. 2022 Sep;
52(4):395-402.
PMID: 36124810
Objective: Although medication adherence (MA) contributes to therapeutic outcome in systemic sclerosis (SSc), research data are scarce. Factors influencing MA in SSc are hardly known. Method: We conducted a monocentric,...
2.
Jendrek S, Glatzel M, Pauli D, Schinke S, Humrich J, Lamprecht P, et al.
Z Rheumatol
. 2022 Mar;
81(8):682-685.
PMID: 35348848
This article describes a hantavirus-associated pronounced myositis as a rare differential diagnosis to polymyositis. The literature on the pathogenesis of hantavirus disease discusses less a direct viral cytopathology but more...
3.
Friedrich S, Luders S, Klotsche J, Burmester G, Riemekasten G, Ohrndorf S
Arthritis Res Ther
. 2020 Jun;
22(1):144.
PMID: 32539806
Background: Digital ulcers (DU) present a challenging complication in systemic sclerosis (SSc). The aim of this study was to combine clinical characteristics and imaging methods to a composite score for...
4.
Butikofer L, Varisco P, Distler O, Kowal-Bielecka O, Allanore Y, Riemekasten G, et al.
Arthritis Res Ther
. 2020 Mar;
22(1):59.
PMID: 32209135
Objectives: To investigate the effect of ACE inhibitors (ACEi) on the incidence of scleroderma renal crisis (SRC) when given prior to SRC in the prospectively collected cohort from the European...
5.
Juche A, Siegert E, Mueller-Ladner U, Riemekasten G, Gunther C, Kotter I, et al.
Z Rheumatol
. 2020 Feb;
79(10):1057-1066.
PMID: 32040755
Background: Raynaud's phenomenon and the frequently ensuing digital ulcerations represent an early and very distressing symptom in patients with systemic sclerosis (scleroderma, SSc) causing significant limitations in the ability to...
6.
Ranjbar M, Rothe M, Klapa S, Lange T, Prasuhn M, Grisanti S, et al.
Scand J Rheumatol
. 2019 Sep;
49(2):141-145.
PMID: 31526060
: Vasculopathy in systemic sclerosis (SSc) is characterized by the obliteration of arterioles and a reduced capillary density in various tissues. In SSc, atrophic alterations of the choroid have been...
7.
Belz D, Moinzadeh P, Riemekasten G, Henes J, Muller-Ladner U, Blank N, et al.
Arthritis Care Res (Hoboken)
. 2019 Jun;
72(8):1041-1048.
PMID: 31150152
Objective: To determine the type and frequency of physical therapy (PT) prescribed by physicians for patients in the registry of the German Network for Systemic Sclerosis. Methods: The data for...
8.
Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, et al.
Clin Rheumatol
. 2019 May;
39(1):27-36.
PMID: 31111363
Introduction: DeSScipher is the first European multicentre study on management of systemic sclerosis (SSc), and its observational trial 1 (OT1) evaluated the efficacy of different drugs for digital ulcer (DU)...
9.
Friedrich S, Luders S, Glimm A, Werner S, Schmittat G, Burmester G, et al.
Arthritis Res Ther
. 2019 Apr;
21(1):96.
PMID: 30987674
Objective: Systemic sclerosis (SSc) can lead to ischemic complications such as digital ulcers (DUs). The aim of the study was to find predictors of DUs by clinical and new imaging...
10.
Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirjak L, et al.
Arthritis Res Ther
. 2019 Jan;
21(1):35.
PMID: 30678703
Background: A consensus on digital ulcer (DU) definition in systemic sclerosis (SSc) has been recently reached (Suliman et al., J Scleroderma Relat Disord 2:115-20, 2017), while for their evaluation, classification...